Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Sobro in conjunction with an investment in Retune
Mandate

Vinge advises Sobro in conjunction with an investment in Retune

September 28, 2020 Employment and Benefits M&A

Vinge has advised Sobro in conjunction with an investment in Retune, a fast‑growing Swedish IT company which has delivered special competence within cloud, IT infrastructure, IT security and workplace services since 2011.

Retune’s head office is located in Stockholm and the company has approximately 70 employees.

Vinge’s team primarily consisted of Johan Winnerblad, Carl Sander, Elsie Nassar, Fredrika Hjelmberg, Nina Gransäter and Lisa Ullman.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026